| IPO Company Profile © ipodata.com |
| Message Board | Quote | Chart | News | SEC Filings | Peer IPO Companies |
| American Medical Systems Holdings, Inc. |
| 10700 Bren Road West, Minnetonka, MN 55343 * (952) 933-4666 |
| Business Description | The Company is the leading independent company focused solely on supplying medical devices to physicians specializing in the treatment of urological disorders. |
| Offering Information Company has | |||
| Trading As | AMMD (NASNTL) | Industry | Manufacturing (SIC 3842) |
| Type of Stock Offered | Common Shares | Filing Date | 5/19/00 |
| Domestic Shares Offered | 6,250,000 | Offer Date | 8/10/00 |
| Foreign Shares Offered | 0 | Filing Range | $11.00 - $13.00 |
| Company Shares | 6,250,000 | Offer Price | $11.00 |
| Selling Shrhldrs Shares | 0 | Gross Spread | $0.770 |
| Gross Proceeds | $68,750,000 | Selling | $0.460 |
| Expenses | - - | Reallowance | $0.100 |
| Post-IPO Shares | 27,190,000 | Employees | - - |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| U.S. Bancorp Piper Jaffray | Lead Manager | (612) 342-6220 |
| Banc of America Securities LLC | Co-manager | (415) 627-2100 |
| Chase H&Q; | Co-manager | (415) 439-3626 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | 3 Months Ending | ||||||
| Figures in U.S. millions except per share data | 12/31/97 | 12/31/98 | 12/31/99 | 3/31/99 | 3/31/00 | ||
| Revenues | - | - | 91.958 | 77.730 | 81.353 | 20.169 | 24.986 |
| Income from Oper. | - | - | 16.335 | -16.977 | -11.621 | -10.765 | 1.904 |
| Net Income | - | - | 10.087 | -11.359 | -9.291 | -7.033 | 0.344 |
| E.P.S | - | - | - | - | - | - | - |
| Revenue Growth (%) | - | - | -15.47 | 4.661 | 23.88 | ||
| Net Income Growth (%) | - | - | - | - | - | ||
| Oper. Profit Margin (%) | - | - | 17.76 | - | - | 7.62 | - |
| Net Profit Margin (%) | - | - | 10.97 | - | - | 1.38 | - |
| Cash Flow - Oper. | 13.90 | 5.83 | -0.33 | ||||
| Cash Flow - Inv. | -39.09 | -1.69 | -4.46 | ||||
| Cash Flow - Fin. | 29.25 | 2.50 | 2.80 | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 3/31/00 | Financial Ratios | ||||
| Total Assets | 190.78 | Current Assets | 46.87 | Current Ratio | 0.98 |
| Total Liab. | 213.01 | Current Liab. | 47.61 | Debt Ratio | 111.65% |
| Total Equity | -22.23 | Working Cap. | -0.74 | Debt to Equity Ratio | - |
| Cash | 5.11 | Return on Assets | 0.18% | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used to repay approximately outstanding indebtedness, to pay contingent purchase price payments relating to our acquisition of Influence, and the balance to fund future product development and acquisition. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Oppenheimer Wolff & Donnelly |
| Bank's Law Firm | Willkie Farr & Gallagher |
| Registrar/Transfer Agent | Norwest Bank of Minnesota |
| Auditor | Ernst & Young |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |
| Principal Shareholders | ||
| Name of Shareholder | % Owned Before | % Owned After |
| Warburg, Pincus Equity Partners, L.P. | ||
| Note: represents ownership of 5% or more prior to the offering. | ||